Henry M. Sarau

11.2k citations

131 papers · 7.5k indexed · 1 hit paper · h-index 45

Molecular Biology top 2%
Immunology top 1%
Cellular and Molecular Neuroscience top 1%
Physiology top 1%
Oncology top 5%

Co-authors: James J. Foley Paulette E. Setler Dulcie B. Schmidt Robert S. Ames Charles L. Zirkle Harry L. Saunders Frank C. Barone Derk J. Bergsma
Topics: Receptor Mechanisms and Signaling (37 papers)Chemokine receptors and signaling (25 papers)Neuropeptides and Animal Physiology (18 papers)
Cited by: Cellular and Molecular Neuroscience Immunology Immunology and Allergy
Journals: Nature Journal of Biological Chemistry Circulation
Partner nations: United States United Kingdom Germany

In The Last Decade

Henry M. Sarau

131 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The central effects of a novel dopamine agonist

1978 578 citations Henry M. Sarau et al. European Journal of Pharmacology profile →

Peers

Countries citing papers authored by Henry M. Sarau

Since Specialization

Citations

This map shows the geographic impact of Henry M. Sarau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry M. Sarau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry M. Sarau more than expected).

Fields of papers citing papers by Henry M. Sarau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry M. Sarau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry M. Sarau. The network helps show where Henry M. Sarau may publish in the future.

Co-authorship network of co-authors of Henry M. Sarau

This figure shows the co-authorship network connecting the top 25 collaborators of Henry M. Sarau. A scholar is included among the top collaborators of Henry M. Sarau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry M. Sarau. Henry M. Sarau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases 2013 ·Journal of Pharmacology and Experimental Therapeutics ·M Salmon,Mark A. Luttmann,James J. Foley,Peter T. Buckley,Dulcie B. Schmidt,Miriam Burman,Edward F. Webb,(unknown),Charles J. Kotzer,Victoria J. Barrett,Robert J. Slack,Henry M. Sarau,Michael R. Palovich,Dramane I. Lainé,Douglas W.P. Hay,William L. Rumsey	64
2	Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD 2009 ·Bioorganic & Medicinal Chemistry Letters ·Zehong Wan,Dramane I. Lainé,Hongxing Yan,(unknown),Katherine L. Widdowson,Peter T. Buckley,Miriam Burman,James J. Foley,Henry M. Sarau,Dulcie B. Schmidt,Edward F. Webb,Kristen E. Belmonte,Michael R. Palovich	2
3	CXCR2 Blockade Impairs Angiotensin II–Induced CC Chemokine Synthesis and Mononuclear Leukocyte Infiltration 2007 ·Arteriosclerosis Thrombosis and Vascular Biology ·Yafa Naim Abu Nabah,(unknown),(unknown),(unknown),Laura Piqueras,Concha López‐Ginés,Henry M. Sarau,Julio Cortijo,Esteban Morcillo,Peter J. Jose,María‐Jesús Sanz	44
4	N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Hong Nie,Katherine L. Widdowson,Michael R. Palovich,(unknown),John D. Elliott,Deborah Bryan,Miriam Burman,Dulcie B. Schmidt,James J. Foley,Henry M. Sarau,Jakob Busch‐Petersen	21
5	The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems 2006 ·British Journal of Pharmacology ·David J. Behm,Gerald P. Stankus,Christopher Doe,Robert N. Willette,Henry M. Sarau,James J. Foley,Dulcie B. Schmidt,Parvathi Nuthulaganti,James A. Fornwald,Robert S. Ames,David G. Lambert,Girolamo Calò,Valeria Camarda,Nambi Aiyar,Stephen A. Douglas	32
6	Comparison of N,N′-diarylsquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Michael R. Palovich,Katherine L. Widdowson,(unknown),Miriam Burman,James J. Foley,Dulcie B. Schmidt,Henry M. Sarau,Martin Rogers,Kevin L. Salyers,Peter D. Gorycki,Theresa J. Roethke,(unknown),Leonard M. Azzarano,Keith W. Ward,Jakob Busch‐Petersen	32
7	Neuromedin Elicits Cytokine Release in Murine Th2-Type T Cell Clone D10.G4.1 2004 ·The Journal of Immunology ·Eric N. Johnson,Edward R. Appelbaum,(unknown),Richard F. Cox,Jyoti Disa,James J. Foley,Sujoy Ghosh,Diane P. Naselsky,Mark Pullen,Henry M. Sarau,(unknown),Klaudia Steplewski,Meirav Zaks‐Zilberman,Nambi Aiyar	43
8	Discovery of potent and orally bioavailable N,N′-diarylurea antagonists for the CXCR2 chemokine receptor 2004 ·Bioorganic & Medicinal Chemistry Letters ·Qi Jin,Hong Nie,(unknown),Katherine L. Widdowson,Michael R. Palovich,John D. Elliott,(unknown),Miriam Burman,Henry M. Sarau,Keith W. Ward,(unknown),(unknown),Peter D. Gorycki,Jakob Busch‐Petersen	32
9	Chemokine-Cytokine Cross-talk 2003 ·Journal of Biological Chemistry ·Bysani Chandrasekar,Peter C. Melby,Henry M. Sarau,Muthuswamy Raveendran,(unknown),Federica M. Marelli‐Berg,Nickolai O. Dulin,Ishwar Singh	90
10	Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models 2001 ·The Journal of Immunology ·Robert S. Ames,Dennis Lee,James J. Foley,Anthony J. Jurewicz,Mark Tornetta,Wilfried Bautsch,(unknown),Andreas Klos,Karl F. Erhard,Russell D. Cousins,Anthony C. Sulpizio,J. Paul Hieble,Gerald P. McCafferty,Keith W. Ward,Jerry L. Adams,William E. Bondinell,David C. Underwood,Ruth R. Osborn,Alison M. Badger,Henry M. Sarau	160
11	Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2 2001 ·Bioorganic & Medicinal Chemistry Letters ·Dashyant Dhanak,(unknown),Michael G. Darcy,Richard M. Keenan,Steven D. Knight,(unknown),Lance H. Ridgers,Henry M. Sarau,(unknown),John R. White,Lily Zhang	23
12	Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1 2001 ·Bioorganic & Medicinal Chemistry Letters ·Dashyant Dhanak,(unknown),Michael G. Darcy,Anthony J. Jurewicz,Richard M. Keenan,(unknown),Henry M. Sarau,Katherine L. Widdowson,John R. White	16
13	Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration 1998 ·Journal of Biological Chemistry ·John R. White,Judithann M. Lee,Peter R. Young,Robert Hertzberg,Anthony J. Jurewicz,Margery A. Chaikin,Katherine L. Widdowson,James J. Foley,Lenox D. Martin,Don E. Griswold,Henry M. Sarau	341
14	Complement Depletion Improves Neurological Function in Cerebral Ischemia 1998 ·Brain Research Bulletin ·U. S. Vasthare,Frank C. Barone,Henry M. Sarau,Robert H. Rosenwasser,Michael J. DiMartino,William F. Young,Ronald F. Tuma	63
15	Synthesis of structural analogs of leukotriene B4 and their receptor binding activity 1993 ·Journal of Medicinal Chemistry ·William D. Kingsbury,Israil Pendrak,Jack D. Leber,Jeffrey C. Boehm,(unknown),Henry M. Sarau,(unknown),Dulcie B. Schmidt,R. A. DAINES	12
16	Stimulation of leukotriene production and membrane translocation of 5-lipoxygenase by cross-linking of the IgE receptors in RBL-2H3 cells 1992 ·Biochemistry ·Angela Wong,Michael N. Cook,(unknown),Henry M. Sarau,James J. Foley,Stanley T. Crooke	34
17	15-acetylthioxy-furodysinin lactone, isolated from a marine sponge , SP. is a potent agonist to human leukotriene B4 receptor 1990 ·Prostaglandins ·Seymour Mong,Bartholomew J. Votta,Henry M. Sarau,(unknown),Dulcie B. Schmidt,Brad Carté,(unknown),John Westley	6
18	Effects of KC 2450 on the lower esophageal sphincter in vivo and in vitro 1987 ·European Journal of Pharmacology ·Philip J. Fowler,Allen H. Nelson,William J. Price,Henry M. Sarau,Marilyn Grous,(unknown),Frank C. Barone,Herbert S. Ormsbee	2
19	Characterization of arachidonate 5-lipoxygenase and leukotriene A4 synthetase from RBL-1 cells 1986 ·M. N. Cook,G. Kurt Hogaboom,Henry M. Sarau,(unknown),Stanley T. Crooke	1
20	Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities. 1986 ·Molecular Pharmacology ·G. Kurt Hogaboom,M. N. Cook,John F. Newton,Angela Varrichio,Robert Shorr,Henry M. Sarau,Stanley T. Crooke	85

About Henry M. Sarau

Henry M. Sarau is a scholar working on Immunology, Toxicology and Immunology and Allergy, having authored 131 papers that have together received 7.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (37 papers), Chemokine receptors and signaling (25 papers) and Neuropeptides and Animal Physiology (18 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.8k citations), Immunology (1.9k citations) and Immunology and Allergy (483 citations). Henry M. Sarau has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include James J. Foley, Paulette E. Setler, Dulcie B. Schmidt, Robert S. Ames, Charles L. Zirkle, Harry L. Saunders, Frank C. Barone, Derk J. Bergsma, Stanley T. Crooke and John R. White. Their work appears in journals such as Nature, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact